Abstract
Purpose
To examine differences in longer-term breastfeeding outcomes among mothers of preterm infants according to domperidone exposure status, as well as examine the potential for effect modification according to maternal weight.
Methods
Retrospective cohort study of 198 mothers of very preterm infants (born ≤ 30 weeks’ gestation) who initiated breastfeeding and whose infants survived until hospital discharge. Data on domperidone use were obtained from hospital pharmacy records, with the primary outcome defined as continuation of breastfeeding at infant discharge from the Neonatal Unit. The relationship between domperidone exposure and breastfeeding status was investigated using multivariable regression analysis, adjusting for potential confounders. Additional pre-determined analyses were undertaken following stratification according to maternal weight to investigate the presence of effect modification.
Results
No overall difference was observed in the proportion of mothers continuing to breastfeed at the time of infant discharge from the Neonatal Unit according to whether or not they received domperidone (aRR 0.99; 0.86–1.13). Notably, effect modification was observed according to maternal weight, with use of domperidone associated with a reduced likelihood of breastfeeding at discharge among women ≥ 70 kg (aRR 0.72; 0.54–0.97), but not among those < 70 kg (aRR 1.16; 0.92–1.46).
Conclusions
Despite experiencing low milk supply, longer-term breastfeeding outcomes were similar between women who did and did not use domperidone. Differences in domperidone effectiveness according to maternal weight have important implications for clinical practice given the increasing prevalence of overweight/obesity in reproductive-age women and their higher risk of low milk supply, highlighting the importance of further research in this area.
Similar content being viewed by others
References
Grzeskowiak LE, Amir LH (2014) Pharmacological management of low milk supply with domperidone: separating fact from fiction. Med J Aust 201(5):257–258
Grzeskowiak LE, Smithers LG, Amir LH, Grivell RM (2018) Domperidone for increasing breast milk volume in mothers expressing breast milk for their preterm infants—a systematic review and meta-analysis. BJOG. https://doi.org/10.1111/1471-0528.15177
Campbell-Yeo ML, Allen AC, Joseph K, Ledwidge JM, Caddell K, Allen VM, Dooley KC (2010) Effect of domperidone on the composition of preterm human breast milk. Pediatrics 125(1):e107–e114
Asztalos EV, Campbell-Yeo M, da Silva OP, Ito S, Kiss A, Knoppert D (2017) Enhancing human milk production with domperidone in mothers of preterm infants: results from the EMPOWER trial. J Hum Lact 33(1):181–187
Grzeskowiak LE, Dalton JA, Fielder AL (2015) Factors associated with domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact 31(2):249–253
Amir LH, Donath S (2007) A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy Childbirth 7(1):9
Grzeskowiak LE, Lim SW, Thomas AE, Ritchie U, Gordon AL (2013) Audit of domperidone use as a galactogogue at an Australian tertiary teaching hospital. J Hum Lact 29(1):32–37
Gilmartin C, Amir LH, Ter M, Grzeskowiak L (2017) Using domperidone to increase breast milk supply: a clinical practice survey of Australian neonatal units. J Pharm Pract Res 47(6):426–430. https://doi.org/10.1002/jppr.1289
Knol MJ, VanderWeele TJ (2012) Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 41(2):514–520
Rasmussen KM, Kjolhede CL (2004) Prepregnant overweight and obesity diminish the prolactin response to suckling in the first week postpartum. Pediatrics 113(5):e465-e471
Huang YC, Colaizzi JL, Bierman RH, Woestenborghs R, Heykants JJ (1986) Pharmacokinetics and dose proportionality of domperidone in healthy volunteers. J Clin Pharmacol 26(8):628–632
Funding
LEG receives salary support through an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1070421). LHA receives salary support through an Australian National Health and Medical Research Council (NHMRC) Translating Research into Practice Fellowship (APP1132522). Funders had no role in any aspects of the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the Women’s and Children’s Health Network Human Research Ethics Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Grzeskowiak, L.E., Amir, L.H. & Smithers, L.G. Longer-term breastfeeding outcomes associated with domperidone use for lactation differs according to maternal weight. Eur J Clin Pharmacol 74, 1071–1075 (2018). https://doi.org/10.1007/s00228-018-2470-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-018-2470-0
